| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.56▼ | 3.55▼ | 3.55▼ | 3.62▼ | 3.64▼ |
| MA10 | 3.55▼ | 3.57▼ | 3.55▼ | 3.73▼ | 4.11▼ |
| MA20 | 3.57▼ | 3.52▲ | 3.52▲ | 3.77▼ | 4.45▼ |
| MA50 | 3.49▲ | 3.67▼ | 3.72▼ | 4.36▼ | 5.41▼ |
| MA100 | 3.70▼ | 3.74▼ | 3.78▼ | 4.47▼ | 6.30▼ |
| MA200 | 3.75▼ | 4.10▼ | 4.24▼ | 5.48▼ | 11.36▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.013▲ | 0.019▲ | -0.007▼ | -0.082▼ |
| RSI | 47.582▼ | 46.629▼ | 45.822▼ | 37.090▼ | 37.432▼ |
| STOCH | 62.500 | 31.798 | 60.185 | 36.831 | 8.265▼ |
| WILL %R | -70.000 | -72.222 | -36.111 | -71.062 | -92.174▼ |
| CCI | -81.450 | -48.255 | 28.768 | -121.889▼ | -111.839▼ |
| ▲ GAP | $SCYX Open Gap Up %2 | Set Alert |
|
Wednesday, October 07, 2026 07:09 AM
JERSEY CITY - SCYNEXIS, Inc. (NASDAQ: SCYX), a clinical-stage biotechnology company advancing novel therapies for severe rare diseases, announced completion of a Phase 1 study of SCY-770, a ...
|
|
Tuesday, August 25, 2026 12:06 PM
JERSEY CITY, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX), a clinical-stage biotechnology company focused on developing innovative therapies for severe and difficult-to-treat ...
|
|
Thursday, March 12, 2026 12:37 AM
On February 26, 2026, SCYNEXIS, Inc. (NASDAQ:SCYX) announced that the first participants had been dosed in a Phase 1 single ascending dose and multiple ascending dose trial evaluating the intravenous ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/11/26 | 3.58 | 3.635 | 3.496 | 3.50 | 50,957 |
| 06/11/26 | 3.34 | 3.5852 | 3.34 | 3.50 | 24,714 |
| 05/11/26 | 3.67 | 3.715 | 3.2801 | 3.30 | 133,699 |
| 04/11/26 | 3.99 | 4.00 | 3.84 | 3.84 | 22,421 |
| 03/11/26 | 3.81 | 3.98 | 3.81 | 3.94 | 51,981 |
| 02/11/26 | 3.83 | 3.90 | 3.72 | 3.81 | 62,935 |
| 30/10/26 | 3.78 | 3.885 | 3.67 | 3.77 | 117,787 |
| 29/10/26 | 3.97 | 4.04 | 3.72 | 3.86 | 133,504 |
| 28/10/26 | 3.77 | 3.95 | 3.77 | 3.95 | 53,872 |
| 27/10/26 | 3.84 | 3.90 | 3.6601 | 3.80 | 43,178 |
|
|
||||
|
|
||||
|
|